{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:56:57Z","timestamp":1790578617567,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.josat.2026.210118","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:58:33Z","timestamp":1789747113000},"page":"210118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between medications for opioid use disorder and child removals"],"prefix":"10.1016","volume":"192","author":[{"given":"Troy","family":"Quast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Delcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.210118_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108780","article-title":"Is buprenorphine treatment availability associated with decreases in substantiated cases of child maltreatment?","volume":"139","author":"Ali","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2026.210118_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09645292.2023.2206594","article-title":"Local prescription opioid use and academic achievement","volume":"31","author":"Bentz","year":"2023","journal-title":"Education Economics"},{"issue":"1","key":"10.1016\/j.josat.2026.210118_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/00027162221142644","article-title":"Effects of opioid treatment programs on child well-being","volume":"703","author":"Bullinger","year":"2022","journal-title":"The Annals of the American Academy of Political and Social Science"},{"issue":"4","key":"10.1016\/j.josat.2026.210118_bb0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/coep.12523","article-title":"What about the children? How opioid use affects child well-being","volume":"39","author":"Bullinger","year":"2021","journal-title":"Contemporary Economic Policy"},{"key":"10.1016\/j.josat.2026.210118_bb0025","series-title":"Definitions of child abuse and neglect","author":"Child Welfare Information Gateway","year":"2016"},{"key":"10.1016\/j.josat.2026.210118_bb0030","series-title":"Parental drug use as child abuse","author":"Child Welfare Information Gateway","year":"2016"},{"key":"10.1016\/j.josat.2026.210118_bb9010","series-title":"Definitions of Child Abuse and Neglect","author":"Child Welfare Information Gateway","year":"2019"},{"key":"10.1016\/j.josat.2026.210118_bb0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008\u20132013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"25","key":"10.1016\/j.josat.2026.210118_bb0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: Population estimates \u2014 United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1016\/j.josat.2026.210118_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/10775595251337073","article-title":"The impact of data suppression on re-identification risk and data access in the National Child Abuse and Neglect Data System","volume":"31","author":"Eiermann","year":"2026","journal-title":"Child Maltreatment"},{"key":"10.1016\/j.josat.2026.210118_bb0055","series-title":"National and state estimates of children living with parents using substances, 2015\u20132019","author":"Ghertner","year":"2022"},{"key":"10.1016\/j.josat.2026.210118_bb0060","series-title":"Availability of treatment for opioid use disorder in areas of high foster care increases","author":"Ghertner","year":"2020"},{"issue":"4","key":"10.1016\/j.josat.2026.210118_bb0065","first-page":"727","article-title":"Average daily dose trajectories for episodes of buprenorphine treatment for opioid use disorder","volume":"45","author":"Hayes","year":"2024","journal-title":"Substance Use & Addiction Journal"},{"issue":"2","key":"10.1016\/j.josat.2026.210118_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.josat.2026.210118_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1115","article-title":"An analysis of patterns of distribution of buprenorphine in the United States using ARCOS, Medicaid, and Medicare databases","volume":"11","author":"Hsu","year":"2023","journal-title":"Pharmacology Research & Perspectives"},{"key":"10.1016\/j.josat.2026.210118_bb0080","series-title":"Opioid prescribing rates and criminal justice and health outcomes","author":"Jennings","year":"2020"},{"issue":"8","key":"10.1016\/j.josat.2026.210118_bb0085","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamapsychiatry.2024.0810","article-title":"Estimated number of children who lost a parent to drug overdose in the US from 2011 to 2021","volume":"81","author":"Jones","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.josat.2026.210118_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/haschl\/qxad061","article-title":"Methadone prescribing by addiction specialists likely to leave communities without available methadone treatment","volume":"1","author":"Joudrey","year":"2023","journal-title":"Health Affairs Scholar"},{"issue":"4","key":"10.1016\/j.josat.2026.210118_bb0095","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/add.70264","article-title":"Variations in US county-level trends in buprenorphine use, 2018\u20132022","volume":"121","author":"Lefler","year":"2026","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.210118_bb0100","series-title":"METHADOSE Oral Concentrate (methadone hydrochloride oral concentrate USP) [Prescribing information]","author":"Mallinckrodt Pharmaceuticals","year":"2016"},{"issue":"7","key":"10.1016\/j.josat.2026.210118_bb0110","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamapediatrics.2025.0828","article-title":"US children living with a parent with substance use disorder","volume":"179","author":"McCabe","year":"2025","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.josat.2026.210118_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114992","article-title":"Geographic disparities in access to medication for opioid use disorder across US census tracts based on treatment utilization behavior","volume":"302","author":"Mitchell","year":"2022","journal-title":"Social Science & Medicine"},{"issue":"10","key":"10.1016\/j.josat.2026.210118_bb0120","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1176\/appi.ajp.2018.17101112","article-title":"Medications for alcohol and opioid use disorders and risk of suicidal behavior, accidental overdoses, and crime","volume":"175","author":"Molero","year":"2018","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.josat.2026.210118_bb9000","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107623","article-title":"Opioid prescription rates and risk for substantiated child abuse and neglect: A Bayesian spatiotemporal analysis","volume":"205","author":"Morris","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.210118_bb0125","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019"},{"key":"10.1016\/j.josat.2026.210118_bb0130","series-title":"Vintage 2020 postcensal estimates of the resident population of the United States (April 1, 2010, July 1, 2010-July 1, 2020)","author":"National Center for Health Statistics","year":"2021"},{"key":"10.1016\/j.josat.2026.210118_bb0135","author":"National Center for Health Statistics"},{"key":"10.1016\/j.josat.2026.210118_bb0140","author":"National Data Archive on Child Abuse and Neglect"},{"issue":"1","key":"10.1016\/j.josat.2026.210118_bb0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1526-4637.2004.04001.x","article-title":"Trends in medical use and abuse of sustained-release opioid analgesics: A revisit","volume":"5","author":"Novak","year":"2004","journal-title":"Pain Medicine"},{"key":"10.1016\/j.josat.2026.210118_bb0150","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.chiabu.2018.10.001","article-title":"State-level variation in the relationship between child removals and opioid prescriptions","volume":"86","author":"Quast","year":"2018","journal-title":"Child Abuse & Neglect"},{"key":"10.1016\/j.josat.2026.210118_bb0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addbeh.2019.01.015","article-title":"The relationship between foster care entries and high-dose opioid prescribing in California","volume":"93","author":"Quast","year":"2019","journal-title":"Addictive Behaviors"},{"issue":"1","key":"10.1016\/j.josat.2026.210118_bb0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1377\/hlthaff.2017.1023","article-title":"Opioid prescription rates and child removals: Evidence from Florida","volume":"37","author":"Quast","year":"2018","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2026.210118_bb0165","series-title":"How to download and use the DEA pain pills database","author":"Rich","year":"2023"},{"key":"10.1016\/j.josat.2026.210118_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13034-019-0266-3","article-title":"The effects of parental opioid use on the parent-child relationship and children\u2019s developmental and behavioral outcomes: A systematic review of published reports","volume":"13","author":"Romanowicz","year":"2019","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"key":"10.1016\/j.josat.2026.210118_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhealeco.2019.01.001","article-title":"Drivers of the fatal drug epidemic","volume":"64","author":"Ruhm","year":"2019","journal-title":"Journal of Health Economics"},{"issue":"4","key":"10.1016\/j.josat.2026.210118_bb0180","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.josat.2026.210118_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-073765","article-title":"State-level variation in distribution of oxycodone and opioid-related deaths from 2000 to 2021: An ecological study of ARCOS and CDC WONDER data in the USA","volume":"14","author":"Solgama","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.josat.2026.210118_bb0190","series-title":"Drug overdose deaths in the United States, 2002-2022 (NCHS Data Brief No. 491)","author":"Spencer","year":"2024"},{"key":"10.1016\/j.josat.2026.210118_bb0195","series-title":"Stata statistical software: Release 19 [Computer software]","author":"StataCorp","year":"2025"},{"key":"10.1016\/j.josat.2026.210118_bb0200","series-title":"Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants (HHS Publication No. SMA 18-5054)","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"10.1016\/j.josat.2026.210118_bb0205","series-title":"Federal guidelines for opioid treatment programs (HHS Publication No. PEP24-02-011)","author":"Substance Abuse and Mental Health Services Administration","year":"2024"},{"key":"10.1016\/j.josat.2026.210118_bb9005","doi-asserted-by":"crossref","DOI":"10.1016\/j.childyouth.2021.106249","article-title":"Impact of Medicaid expansion and methadone coverage as a medication for opioid use disorder on foster care entries during the opioid crisis","volume":"130","author":"Tang","year":"2021","journal-title":"Children and Youth Services Review"},{"issue":"2","key":"10.1016\/j.josat.2026.210118_bb0210","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1176\/appi.ps.201300256","article-title":"Medication-assisted treatment with buprenorphine: Assessing the evidence","volume":"65","author":"Thomas","year":"2014","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.josat.2026.210118_bb0215","author":"U.S. Census Bureau"},{"key":"10.1016\/j.josat.2026.210118_bb0220","author":"U.S. Census Bureau"},{"key":"10.1016\/j.josat.2026.210118_bb0225","series-title":"Rural-urban continuum codes","author":"U.S. Department of Agriculture, Economic Research Service","year":"2024"},{"key":"10.1016\/j.josat.2026.210118_bb0230","series-title":"AFCARS report #27","author":"U.S. Department of Health and Human Services","year":"2020"},{"key":"10.1016\/j.josat.2026.210118_bb0235","author":"U.S. Department of Justice, Drug Enforcement Administration"},{"key":"10.1016\/j.josat.2026.210118_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2025.209681","article-title":"Prenatal opioid use disorder and child protective service involvement: Does consistent treatment matter?","volume":"172","author":"Wang","year":"2025","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.210118_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112795","article-title":"Personally-tailored opioid-overdose and medication for opioid use disorder (MOUD) education (TOME) significantly increases MOUD and overdose knowledge in peripartum individuals: Results from a randomized controlled pilot trial","volume":"275","author":"Winhusen","year":"2025","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2026.210118_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1176\/appi.ps.201900150","article-title":"Relationship of county opioid epidemic severity to changes in access to substance use disorder treatment, 2009-2017","volume":"71","author":"Yarbrough","year":"2020","journal-title":"Psychiatric Services"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:30:11Z","timestamp":1790577011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926002389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":51,"alternative-id":["S2949875926002389"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210118","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between medications for opioid use disorder and child removals","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"210118"}}